Introduction
Colicins are plasmid-encoded bactericidal proteins produced by immune Escherichia coli that are active against sensitive E. coli and its closely related cells. Their toxic activities are of various types: some colicins form ion channels in the cytoplasmic membrane of sensitive cells, while others act as nucleases that degrade DNA or 16S RNA in the cytoplasm. One colicin, colicin M, inhibits the biosynthesis of murein (Lakey et al., 1994) . Their toxic activities against target cells are known to occur in 3 distinct stages ( Figure 1 ). First is receptor recognition and binding, where colicins bind to a specific receptor at the cell surface. Second is the translocation step, where colicins cross both the outer membrane and the periplasm to reach their cellular target (Lakey et al., 1994; Lazdunski, 1995) . The final stage is the killing action, where colicins exert their lethal effects by forming a pore in the cytoplasmic membrane (Lazdunski, 1995) , by DNAse or RNAse activity, or by inhibiting murein biosynthesis in the cytoplasm (Lakey et al., 1994) .
Colicins have 3 linearly organized functional domains, each domain implicated in a specific stage of the colicin activity. As shown in Figure 1 , the central domain (R-domain) is responsible for the receptor-binding activity. The N-terminal domain (T-domain) is involved in translocation. The C-terminal domain (P-domain) carries out the lethal activity; this domain either forms a voltagegated pore in the cytoplasmic membrane or digests nucleic acids in the cytoplasm Vetter et al., 1998; Papadokus et al., 2011) .
Colicin N is a group A (Tol-dependent) pore-forming colicin whose target receptor is the E. coli outer membrane protein OmpF (Pugsley, 1987) . It is composed of a largely unstructured T-domain linked by a glycine-rich sequence to a central R-domain containing a 6-stranded β-sheet structure. The R-domain is connected to the P-domain (a 10 α-helical structure) by means of a 65 Å α-helix (ElKouhen et al., 1993; Gokce et al., 2000) . While receptor binding and pore formation have been extensively studied, much remains unknown about the translocation step. Colicin N translocation requires 3 members of the Tol locus: TolA, TolQ, and TolR (Webster, 1991) . TolQ and TolR are integral membrane proteins of the E. coli inner membrane and there is no evidence that they reach across the periplasm to the outer membrane. However, TolA is thought to span the periplasm by means of its extended central domain (TolA-II), which links the N-terminal TolA-1 domain in the cytoplasmic membrane to the C-terminal TolA-III domain (Levengood et al., 1991) . The interaction between TolA-III and the N-terminal domain of colicin N is thought to be the principle event of translocation (Benedetti et al., 1991) .
It has been shown that the 3-domain arrangement of bactericidal colicins is identical to that of the protein g3p of the filamentous phage. During infection of E. coli by this phage, TolA-III binds to the N-terminal domain of g3p protein Holliger et al., 1999) . The structure of the g3p N-terminal domain is known . Further NMR studies and the crystal structure of the g3p-TolA-III complex have shown that extensive conformational change in the N-terminal domain of g3p occurs on interaction with TolA-III (Lubkowski et al., 1999) .
In contrast, there is very little information on the N-terminal domain of any colicin. The T-domain of colicin Ia was found to be largely unstructured. The crystal structure of colicin N lacked the N-terminal 90 residues. Further evidence of an unstructured colicin N T-domain came from structural studies of the isolated T-domain. Fluorescence studies of the isolated domain with TolA-III indicated that the T-domain acquired structure on interaction with TolA-III (Raggett, 1998; Raggett et al., 1998; Gokce et al., 2000; Gökçe and Lakey, 2003; Hecht et al., 2009 ). To investigate this further, a colicin N T-domain-TolA-III fusion was constructed. Its expression in E. coli and purification are presented in this paper. The structure of this complex will not only provide structural information on T-domain of colicins, but will also shed light on the colicin translocation process. By studying 1H-13C-15N NMR isotopically labeled T-domains interacting with unlabeled TolA-III (the C-terminal domain of TolA), Hecht et al. identified the TolA-binding epitope and showed that the extent of its disorder is reduced upon binding to TolA, although it does not fold into a globular structure with defined secondary structure elements. Residues upstream and downstream of the 27-residue TolA-binding epitope remain disordered in the TolA-bound T-domain, as they are in the free T-domain. Figure 2 , construction of pISATolA-III was completed in 2 stages. First, DNA encoding the TolA-III domain was amplified using 2 oligonucleotides (TOLAXHOSENSE:  TTTTTCTCGAGCAACAATGGCGCATCAGGG  and  TOLABMLUREV: TTTTTGGATCCCCCACCCGG TTTGAAGTCCAATGGCGC) with an 18 bp matching sequence to TolA-III and plasmid pSK17 from Citrobacter freundii as a template. The pET8c vector was designed to introduce a 6-histidine and 2-serine linker at the N-terminus of this construct, which facilitates purification via nickel affinity chromatography (Politou et al., 1994; Sandallı et al., 2014) . The DNA fragment encoding TolA-III and an extra BamHI restriction site was included to introduce the T-domain of colicin N into the pET8C vector using XhoI and MluI restriction sites. Second, DNA encoding for the colicin N T-domain was amplified using 2 oligonucleotides (COLNBAMSENSE: TTTTTGGATCCGGTAGTAA  TGG CGCAGATAAT and COLNMLUREV: TTTTTAC  GCGTTATTA TCGATTTCCACTATTCCC) with an 18 bp matching sequence to the colicin N T-domain. The pCol-N-T plasmid was used as a template (Raggett, 1998; Raggett et al., 1998) . The PCR products were gel-purified and ligated into a purified, digested vector. The colicin N T-domain was introduced into a pISA TolA-III plasmid using BamHI and MluI restriction sites. This final construct (pISA-TolA-III-Col-N-T) was used initially to transform E. coli DH5α cells with ampicillin selection. Successful transformants were selected on the basis of miniprep restriction digest analysis or analytical PCR, and a subsequent plasmid preparation was used for DNA sequencing and to transform E. coli BL21 (DE3) cells. DNA sequencing of this plasmid showed that both colicin N T-domains and TolA-III were correctly inserted. A circular plasmid map of this construct is shown in Figure 2 . 2.2. Protein purification E. coli BL21 (DE3) cells were transformed with pISA-TolA-III-Col-N-T and grown in 3 mL O/N cultures of LB medium containing ampicillin (200 µg/mL). A 3 mL O/N culture was introduced into 500 mL of LB containing ampicillin (200 µg/mL) and grown at 37 °C. The cells were induced at OD 600 0.8-0.9 with isopropyl β-D-thiogalactopyranoside (1 mM) and grown for a further 3 h. The cells were harvested and resuspended in 20 mM phosphate and 300 mM NaCl (pH 7.4) containing RNAse (20 µg/mL) and DNAse (20 µg/mL). The cells were lysed by French press and the supernatant was obtained by ultracentrifugation at 40,000 rpm (45 Ti rotor used at 4 °C) for 1 h. The fusion protein was found to be soluble, with none remaining in the cell membrane pellet. The N-terminal 6X histidine tag facilitated purification of the fusion by means of a QIAGEN Ni-NTA affinity column (Hochuli et al., 1987; Chen et al., 2014; Sandallı et al., 2014) . The fusion protein was washed onto the column with a 50 mM phosphate and 300 mM NaCl (pH 8.0) buffer, additionally washed with the same buffer containing 30 mM imidazole, and eluted in 300 mM imidazole (pH 7.0). The fusion protein was analyzed for purity by SDS-PAGE (Figure 3 ). Protein concentration was determined by UV absorption at 280 nm.
Materials and methods
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Circular dichroism spectroscopy
Far-UV circular dichroism (CD) spectroscopy was carried out on a Jobin Yvon CD6 spectrophotometer. Measurements were made at 25 °C using a 0.01 cm path length circular cuvette (Hellma) and protein concentration of 1 mg/mL. The protein was in a 50 mM phosphate and 300 mM NaCl (pH 7.4) buffer; this was also used for baseline subtraction. The CD signal measured was mean residue ∆ɛ (M -1 cm -1 ).
Results and discussion
Details on the construction of pISA-TolA-III-Col-N-T plasmid are given in Figure 2 and Section 2. The pET8c vector was used to clone the genes encoding the colicin N T-domain and TolA-III peptide fragments. This vector is under the tight control of the T7 promoter that facilitates the expression of toxic proteins (Studier and Moffat, 1986; Politou et al., 1994; Yike et al., 1996; Chen et al., 2014) . Our construct also included an N-terminal polyhistidine tag (6 histidines) for simple and efficient protein purification. DNA sequencing of this constructed plasmid (Figure 2) confirmed that the desired inserts were successfully cloned into the pET8C expression vector and also that the fusion constructs were in the correct reading frame. The fusion protein was purified from the E. coli cell lysate as described in Section 2. Ni-NTA agarose resin was used to purify the fusion protein from the supernatant of E. coli cell lysate after ultracentrifugation. Proteins containing the histidine affinity tag were able to bind to the Ni-NTA agarose resin with a greater affinity than other E. coli proteins. Proteins that were not specifically bound were washed through the column without affecting the binding of His-tagged fusion protein. Elution of the fusion protein from the column was achieved by imidazole, which competes with the His tag for interaction with the Ni-NTA resin.
Eluted samples were analyzed on SDS-PAGE and showed a strong protein with a molecular weight of around 20.1 kDa. The calculated molecular weight of the fusion protein using the ProtParam tool was 19,505.1 kDa, which is very close to the experimental molecular weight. The extinction coefficient fusion at 280 nm is 17,780 and its theoretical pI is 9.2 (http://expasy.proteome.org.au/cgibin/protparam). The protein yields were calculated using UV absorbance at 280 nm and the extinction coefficient was 17,780 as taken from the ProtParam tool. One liter of BL21 (DE3) E. coli cell culture gave more than 100 mg (110-120 mg) of highly pure fusion protein.
The event central to the translocation process is the interaction of the colicin T-domain with TolA-III. Studies of colicin have shown that translocation is accelerated in urea, indicating that colicins are likely to unfold to expose the T-domain, allowing interaction with TolA 1 2 3 4 5 6 7 8 9 10 66 kDa 45 kDa 36 kDa 29 kDa 24 kDa 20.1 kDa Figure 3 . TolA-III-colicin N-T domain fusion expression in E. coli BL21 (DE3). 1: Supernatant after ultracentrifugation (before Ni-NTA resin). 2: Flow through Ni-NTA resin. 3: Wash with 20 mM imidazole, 50 mM phosphate, and 300 mM NaCl. 4: Elution fraction 1 in 300 mM imidazole, 50 mM phosphate, and 300 mM NaCl. 5: Elution fraction 2. 6: Molecular weight markers (66 kDa, 45 kDa, 36 kDa, 29 kDa, 24 kDa, 20.1 kDa). 7: Elution fraction 3. 8: Elution fraction 4. 9: Elution fraction 5. 10: Elution fraction 6. (Benedetti et al., 1992) . The structure of the T-domain of any colicin before and after interaction with TolA is still unknown. Despite obtaining the first crystals of residues 36-397 of colicin N (El-Kouhen et al., 1993) , the final solved structure lacked N-terminal 90 residues and gave no structural information on the N-terminal domain structure of colicin N (residues 1-66). The only member of the colicin family whose full-length structure is known is colicin Ia (Wiener et al., 1997) . While its pore-forming domain adopts a similar 10 α-helical fold to colicin N, its N-terminal domain appears largely unstructured. Recent structural studies of the colicin N T-domain substantiate the idea of an unfolded T-domain: 1) Its sequence scores poorly on most secondary structure prediction programs.
2) The CD spectrum of the isolated T-domain shows an unstructured domain.
3) Fluorescence studies of the purified domain shows aqueous exposure of T-domain tryptophans (Raggett, 1998; Papadokus et al., 2011) .
Further CD studies with whole colicin N indicated that in the presence of the R-and P-domains, the T-domain may adopt a weak α-helical structure (Deprez et al., 2002) (Figure 4 ). Fluorescence studies showed that the addition of TolAII-III to the T-domain resulted in a burial of tryptophan, indicating that a conformational change in T-domain had occurred. It is possible that, similarly to colicin A, colicin N unfolds during translocation and releases the weakly structured T-domain, which acquires structure upon interaction with TolA. A substantial conformational change in phage g3p upon interaction with TolA was also observed . Previous NMR studies on colicin N and the N1 domain of the filamentous phage g3p protein demonstrated that TolA-III changes its conformation upon binding to colicin N but retains its global fold Deprez et al., 2002 Deprez et al., , 2005 Hecht et al., 2009) . The nature of these structural changes would be extremely useful in elucidating the events of translocation, and therefore a construct of the T-domain TolA complex was constructed.
The fusion protein consists of 2 different proteins originating from different parent molecules, attached by a flexible glycine-rich linker. The construct we describe here (pISA-TolA-III-Col-N-T) permits the production of colicin N T-domain and TolA-III domain fusion under the tight control of the T7 promoter system. The construct was prepared in this manner to force both proteins to be present in the crystal at equimolar concentration and to achieve the formation of the complex. The addition of an extra histidine tag (6 His) was used for purification of this fusion protein by a single affinity chromatography step. The pET8c construct gives high yields of stable fusion protein and it is a critical step for the crystal structure studies. The secondary structure of colicin N-T-TolA-III fusion protein was determined by CD spectroscopy, which indicated an α-helix + β-sheet structure; therefore, the fusion is structured and further crystallographic work can proceed. Structural knowledge of this fusion will be useful for better understanding colicin N's translocation through the cell envelope of gram-negative bacteria. 
